These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 8993676)

  • 21. Central effects of angiotensin II, its fragment and analogues.
    Georgiev VP; Klousha VE; Petkov VD; Markovska VL; Svirskis SV; Mountsinietse RK; Anouans ZE
    Acta Physiol Pharmacol Bulg; 1984; 10(4):36-43. PubMed ID: 6085530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopaminergic influence on the effects of angiotensin II in behavioural reactions.
    Georgiev V; György L; Yonkov D; Getova D; Markovska V; Petkova B
    Physiol Bohemoslov; 1985; 34 Suppl():45-8. PubMed ID: 3014581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central action of drugs acting on the cholinergic muscarinic receptor. III. Influence of atropine and scopolamine injected intraventricularly on behavior and levels of biogenic amines in the rat brain.
    Zebrowska-Lupina I; Kleinrok Z; Poddubiuk Z
    Arch Immunol Ther Exp (Warsz); 1975; 23(4):485-95. PubMed ID: 1172421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central action of adrenaline.
    Jagiełło-Wójtowicz E
    Acta Physiol Pol; 1981; 32(2):169-80. PubMed ID: 7196677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Neuroleptic-like activity of the tripeptide neurotensin analog GZR-123].
    Guzevatykh LS; Ostrovskaia RU; Gudasheva TA; Zaĭtseva NI; Voronina TA
    Eksp Klin Farmakol; 2002; 65(1):3-6. PubMed ID: 12025780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of central effects of noradrenaline and dopamine injected into the lateral brain ventricle in rats.
    Zebrowska-Lupina I; Malec D; Kleinrok Z
    Acta Physiol Pol; 1975; 26(3):261-74. PubMed ID: 1242288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute cocaine effects in paradoxical sleep deprived male rats.
    Andersen ML; Perry JC; Tufik S
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):245-51. PubMed ID: 15694231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Central activity of 2-amino-3-phosphonopropionic acid (AP3) and its N-methyl analog.
    Winnicka MM; Wiśniewski K; Kupczyk-Subotkowska L; Subotkowski W; Mastalerz P
    Pol J Pharmacol; 1994; 46(5):395-401. PubMed ID: 7894525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cataleptic activity of the denatured venom of the social wasp Agelaia vicina (Hymenoptera, Vespidae) in Rattus norvegicus (Rodentia, Muridae).
    de Oliveira L; Cunha AO; Mortari MR; Coimbra NC; Dos Santos WF
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):198-203. PubMed ID: 16310919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Behavioral activity of 1S,3R-ACPD, an agonist of metabotropic glutamate receptors.
    Zalewska A; Wiśniewski K
    Pol J Pharmacol; 1997 Aug; 49(4):239-48. PubMed ID: 9437767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of fibrinogen degradation products on the action of amphetamine in the central nervous system.
    Zwoliński J; Buczko W
    Pol J Pharmacol Pharm; 1977; 29(3):313-9. PubMed ID: 560684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A search for new active amino acids responsible for pharmacological activity of collagen degradation products.
    Lutostańska A; Telejko E; Maćkowiak J; Wiśniewski K
    Pol J Pharmacol; 1993; 45(3):253-68. PubMed ID: 8220659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Central nervous system depressant activity of Russelia equisetiformis.
    Kolawole OT; Makinde JM; Olajide OA
    Niger J Physiol Sci; 2007; 22(1-2):59-63. PubMed ID: 18379620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Modulation by ultralow intensity electromagnetic fields on pharmacologic effects of psychotropic drugs].
    Shtemberg AS; Bazian AS; Shikhov SN; Cherniakov GM; Uzbekov MG
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2001; 51(3):373-7. PubMed ID: 11550647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological properties of substituted gamma-butyrolactones. I. The effects on the central nervous system.
    Sieroslawska J; Hano J; Sypniewska M; Czarnecki R; Chojnacka-Wójcik E; Harasiewicz A
    Pol J Pharmacol Pharm; 1973; 25(1):1-16. PubMed ID: 4798097
    [No Abstract]   [Full Text] [Related]  

  • 36. Involvement of adenosinergic receptor system in an animal model of tardive dyskinesia and associated behavioural, biochemical and neurochemical changes.
    Bishnoi M; Chopra K; Kulkarni SK
    Eur J Pharmacol; 2006 Dec; 552(1-3):55-66. PubMed ID: 17064683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Valeriana officinalis does not alter the orofacial dyskinesia induced by haloperidol in rats: role of dopamine transporter.
    Fachinetto R; Villarinho JG; Wagner C; Pereira RP; Avila DS; Burger ME; Calixto JB; Rocha JB; Ferreira J
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1478-86. PubMed ID: 17669571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychopharmacological profile of mesterolone.
    Baran L; Przegaliński E
    Pol J Pharmacol Pharm; 1981 Oct; 33(3):299-303. PubMed ID: 7198778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-HT1A receptor agonists buspirone and gepirone attenuate apomorphine-induced aggressive behaviour in adult male Wistar rats.
    Pruus K; Skrebuhhova-Malmros T; Rudissaar R; Matto V; Allikmets L
    J Physiol Pharmacol; 2000 Dec; 51(4 Pt 2):833-46. PubMed ID: 11220492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.